Difficulties in primary diagnosis of HIV infection at the stages of health care settings

Abstract

Aim: to demonstrate the difficulties and timeliness of HIV diagnosis by primary care physicians, to carry out a clinical and epidemiological analysis of newly diagnosed cases of HIV infection.

Materials and methods: The study evaluated the routing of diagnosis and analyzed the epidemiological and clinical and laboratory data of 85 patients with a newly diagnosed HIV infection hospitalized in the St. Petersburg Clinical Infectious Diseases Hospital named after S. P. Botkin during the period from November 2018 to October 2019. To confirm positive results, ELISA and western blot were used.

Results: Among the observed patients, 71.3% were women and 28.7% were men. The average age was 39.3 ± 2 years. Upon admission to the infectious diseases hospital with an established diagnosis of HIV infection, 49.5% were hospitalized in specialized departments (n = 42). Of them, nine (9) were referred by the polyclinic with an established diagnosis, in 20 patients the diagnosis was established in somatic hospitals, and emergency room doctors newly diagnosed HIV infection in 13 more patients. The remaining 50.5% (n = 43) were hospitalized in various departments with other diagnoses. Clinical and laboratory analysis of these patients showed that for the first time in life, an established diagnosis of HIV infection corresponded to both early (15.3%) and late (84.7%) stages of the disease with dominance of sexual transmission of the virus (43.6%).

Conclusion: HIV infection at both early and late stages can manifest under the guise of various other diseases, which makes it necessary to expand testing of patients for HIV infection, including using rapid tests.

Keywords

HIV infection / newly diagnosed HIV infection / early diagnosis

References

[1] State report «O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federatsii v 2018 godu». Moscow: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebiteley i blagopoluchiya cheloveka; 2019. 254 p. (In Russ).

[2] Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2018 году». — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2019. — 254 с.

[3] Belyakov NA, Rassokhin VV, Semenov AV, et al. VICh-infektsiya i komorbidnye sostoyaniya v Severo-Zapadnom federal’nom okruge RF v 2016 godu. Analiticheskiy obzor. St Petersburg: NIIEM im. Pastera; 2017. 52 p. (In Russ).

[4] Беляков Н.А., Рассохин В.В., Семенов А.В., и др. ВИЧ-инфекция и коморбидные состояния в Северо-Западном федеральном округе РФ в 2016 году. Аналитический обзор. — СПб.: НИИЭМ им. Пастера, 2017. — 52 с.

[5] Pokrovskiy VV. VICh-infektsiya i SPID. Natsional’noe rukovodstvo. Moscow: GEOTAR-Media; 2014. 528 p. (In Russ).

[6] Покровский В.В. ВИЧ-инфекция и СПИД. Национальное руководство. — М.: ГЭОТАР-Медиа, 2014. — 528 c.

[7] Ahlström MG, Ronit A, Omland LH, et al. Algorithmic prediction of HIV status using nation-wide electronic registry data. E Clinical Medicine. 2019;17:100203. doi: 10.1016/j.eclinm.2019.10.016.

[8] Ahlström M.G., Ronit A., Omland L.H., Vedel S., Obel N. Algorithmic prediction of HIV status using nation-wide electronic registry data. E Clinical Medicine. 2019;17:100203. doi: 10.1016/j.eclinm.2019.10.016.

[9] Late presenters working group in COHERE in EuroCoord; Mocroft A, Lundgren J, et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30070.

[10] Late presenters working group in COHERE in EuroCoord; Mocroft A., Lundgren J., et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20:47. doi: 10.2807/1560-7917.ES.2015.20.47.30070.

[11] HIV Causal Collaboration; Ray M, Logan R, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (London, England). 2010;24(1):123–137. doi: 10.1097/QAD.0b013e3283324283.

[12] HIV Causal Collaboration; Ray M., Logan R., et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (London, England). 2010;24(1):123–137. doi: 10.1097/QAD.0b013e3283324283.

[13] Ma ZM, Stone M, Piatak MJr, et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol. 2009;83(7):3288–3297. doi: 10.1128/JVI.02423-08.

[14] Ma Z.M., Stone M., Piatak M. Jr., et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol. 2009;83(7):3288–3297. doi: 10.1128/JVI.02423-08.

[15] Reference: HIV infection in the Russian Federation in the first half of 2019. Available at: http://aids-centr.perm.ru/images/4/hiv_in_russia/hiv_in_rf_30.06.2019.pdf (accessed 03 June 2019).

[16] Справка: ВИЧ-инфекция в Российской Федерации в первом полугодии 2019 г. Доступ по http://aids-centr.perm.ru/images/4/hiv_in_russia/hiv_in_rf_30.06.2019.pdf (дата обращения: 03.06.2019).

[17] Bartlett JG, Redfield RR, Pham PA, Mazus AI. Clinical aspects of HIV infection. Russian edition. [Klinicheskie aspekty VICh-infektsii. Rossiyskoe izdanie]. Мoscow: GRANAT; 2013. 696 p. (In Russ).

[18] Бартлетт Дж., Редфилд Р., Фам П., Мазус А.И. Клиничес-кие аспекты ВИЧ-инфекции. Российское издание. — М.: ГРАНАТ, 2013. — 696 с.

[19] Lin TY, Yang CJ, Liu CE, et al. Clinical features of acute human immunodeficiency virus infection in Taiwan: a multicenter study. J Microbiol Immunol Infect. 2019;52(5):700–709. doi: 10.1016/j.jmii.2018.01.005.

[20] Lin T.Y., Yang C.J., Liu C.E., et al. Clinical features of acute human immunodeficiency virus infection in Taiwan: a multicenter study. J Microbiol Immunol Infect. 2019;52(5):700–709. doi: 10.1016/j.jmii.2018.01.005.

[21] Rosenberg NE, Pilcher CD, Busch MP, Cohen M.S. How can we better identify early HIV infections? Curr Opin HIV AIDS. 2015;10(1):61–68. doi: 10.1097/COH.0000000000000121.

[22] Rosenberg N.E., Pilcher C.D., Busch M.P., Cohen M.S. How can we better identify early HIV infections? // Curr Opin HIV AIDS. 2015;10(1):61–68. doi: 10.1097/COH.0000000000000121.

[23] Tsykin DB, Lantsova NA, Shcherba YuV, et al. Changes in internal organs with drug and substance abuse. Sovetskaya meditsina. 1991;54(3):78–80. (In Russ).

[24] Цыкин Д.Б., Ланцова Н.А., Щерба Ю.В., и др. Изменения внутренних органов при нарко- и токсикоманиях. Советская медицина. 1991;54(3):78–80.

[25] Novak KE. Clinical and morphological characteristics of subcompensated and decompensated liver cirhosis of viral etiology. Pediatr. 2011;2(2):47–52. (In Russ).

[26] Новак К.Е. Клинико-морфологическая характеристика субкомпенсированного и декомпенсированного цирроза печени вирусной этиологии. Педиатр. 2011;2(2):47–52.

[27] Ermak TN, Samitova ER, Tokmalaev AK, Kravchenko AV. Current course of pneumocystic pneumonia in HIV-infected patients. Terapevticheskiy arkhiv. 2011;(11):19–24. (In Russ).

[28] Ермак Т.Н., Самитова Э.Р., Токмалаев А.К., Кравченко А.В. Современное течение пневмоцистной пневмонии у больных с ВИЧ-инфекцией. Терапевтический архив. 2011;11:19–24.

[29] Levanovich VV, Timchenko VN, Arkhipova YuA, et al. VICh-infe-ktsiya na rubezhe vekov: Rukovodstvo dlya vrachey vsekh spetsi-al’nostey. St Petersburg: Izdatel’stvo N-L; 2012. 496 p. (In Russ).

[30] Леванович В.В., Тимченко В.Н., Архипова Ю.А., и др. ВИЧ-инфекция на рубеже веков: Руководство для врачей всех специальностей. — СПб.: Издательство Н-Л, 2012. — 496 с.

[31] Lu W, Mehraj V, Vyboh K, et al. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc. 2015;18(1):20052. doi: 10.7448/IAS.18.1.20052.

[32] Lu W., Mehraj V., Vyboh K., et al. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc. 2015;18(1):20052. doi: 10.7448/IAS.18.1.20052.

[33] Miedzinski LJ. Early clinical signs and symptoms of HIV infection: delaying progression to AIDS. Can Fam Physician. 1992;38:1401–1410.

[34] Miedzinski L.J. Early clinical signs and symptoms of HIV infection: delaying progression to AIDS. Can Fam Physician. 1992;38:1401–1410.

[35] Lang S, Mary-Krause M, Cotte L, et al. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med. 2010;170(14):1228–1238. doi: 10.1001/archinternmed.2010.197.

[36] Lang S., Mary-Krause M., Cotte L., et al. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med. 2010;170(14):1228–1238. doi: 10.1001/archinternmed.2010.197.

RIGHTS & PERMISSIONS

Eco-vector